Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Insulet: medical device reports filed with FDA

330,394 reports name it as the manufacturer of the device involved, 2006–2026.

330,394
reports naming it as manufacturer
1.3% of all MAUDE reports
89,296
reports, 12 months to August 2026
56,328 in the 12 months before
88.1%
classified as malfunction
62.3% across all reports
0.1%
classified as death, as reported
0.9% across all reports

330,394 medical device reports received by FDA give Insulet as the manufacturer of the device involved, 1.3% of the MAUDE database, from June 2006 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

89,296 reports arrived in the 12 months to August 2026, up 59% from 56,328 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (88.1%), injury (11.6%) and other (0.2%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
Omnipod 5 PodAlternate controller enabled insulin infusion pump72,51613,9130.1%
Omnipod DASH Insulin Management SystemPump, infusion, insulin62,6465,5630.1%
Omnipod 5 PodsAlternate controller enabled insulin infusion pump53,25334,5930%
Omnipod 5 Automated Insulin Delivery SystemAlternate controller enabled insulin infusion pump50,52332,4780%
OmniPod Insulin PumpPump, infusion, insulin45,1181450.3%
Omnipod Insulin Management SystemPump, infusion, insulin37,5802180.1%
Omnipod DASH, PODS 10-PACKPump, infusion, insulin4,9451,0220%
Omnipod 5 ControllerAlternate controller enabled insulin infusion pump2,6189260.8%
Omnipod 5Alternate controller enabled insulin infusion pump2431640.8%
Omnipod DASH, PDM, Personal Diabetes ManagerPump, infusion, insulin151270.7%
PodDevice, neurovascular embolization1180%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
QFGAlternate controller enabled insulin infusion pump179,53854.3%
LZGPump, infusion, insulin150,93345.7%
LFRGlucose dehydrogenase, glucose270%
KGXTape and bandage, adhesive160%
QJIInteroperable automated glycemic controller160%
NBWSystem, test, blood glucose, over the counter130%
FRNPump, infusion80%
OYCPump, infusion, insulin, to be used with invasive glucose sensor50%
NDCCalculator, drug dose20%
LZHPump, infusion, enteral10%

Reports by month, five years

05,61811,235Sep 2021: 2,050Oct 2021: 2,349Nov 2021: 1,819Dec 2021: 1,9332022Jan 2022: 1,787Feb 2022: 1,728Mar 2022: 1,871Apr 2022: 1,633May 2022: 1,875Jun 2022: 2,127Jul 2022: 2,294Aug 2022: 2,560Sep 2022: 2,293Oct 2022: 2,241Nov 2022: 1,861Dec 2022: 2,5612023Jan 2023: 2,994Feb 2023: 2,815Mar 2023: 2,858Apr 2023: 2,419May 2023: 2,768Jun 2023: 2,993Jul 2023: 2,642Aug 2023: 3,579Sep 2023: 3,916Oct 2023: 3,737Nov 2023: 3,147Dec 2023: 3,3312024Jan 2024: 3,612Feb 2024: 3,949Mar 2024: 3,780Apr 2024: 4,352May 2024: 4,540Jun 2024: 4,008Jul 2024: 5,364Aug 2024: 5,186Sep 2024: 4,840Oct 2024: 4,924Nov 2024: 3,937Dec 2024: 3,6442025Jan 2025: 4,664Feb 2025: 4,004Mar 2025: 5,257Apr 2025: 4,995May 2025: 4,641Jun 2025: 5,510Jul 2025: 5,360Aug 2025: 4,552Sep 2025: 6,316Oct 2025: 7,821Nov 2025: 6,484Dec 2025: 5,7582026Jan 2026: 4,834Feb 2026: 6,130Mar 2026: 6,370Apr 2026: 7,574May 2026: 7,079Jun 2026: 9,156Jul 2026: 11,235Aug 2026: 10,539

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death0.1%356
Injury11.6%38,266
Malfunction88.1%291,037
Other0.2%653
Not given0%82

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Insulet reports

How many FDA device reports name Insulet as manufacturer?

330,394 reports through August 2026, 89,296 of them in the latest 12 months.

Which of its brands appear most often?

Omnipod 5 Pod (72,516), Omnipod DASH Insulin Management System (62,646), Omnipod 5 Pods (53,253), Omnipod 5 Automated Insulin Delivery System (50,523) and OmniPod Insulin Pump (45,118).

Which device types does it report on?

alternate controller enabled insulin infusion pump (54.3%), pump, infusion, insulin (45.7%), glucose dehydrogenase, glucose (0%) and tape and bandage, adhesive (0%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.